Global Bioprinting Technologies Market

Bioprinting Technologies Comprehensive Study by Application (Tissue Engineering, Drug Development/ Screening, Toxicology Screening, Tissue Model for Cancer Research, Others), Technology (Microextrusion Bioprinting, Inkjet 3D Bioprinting, Laser assisted Bioprinting, Stereo lithography, Others), Material (Living Cells, Hydrogels, Extracellular Matrices), End User (Pharmaceutical & Biotechnology, Research & Organization, Academic Institute, Hospital, Others) Players and Region - Global Market Outlook to 2030

Bioprinting Technologies Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 6.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Bioprinting Technologies
Bioprinting technology refers to advanced methods used to create three-dimensional (3D) structure, tissues, and even organ using biological materials such as living cells, biomaterials, and bioinks. It is a revolutionary field at the intersection of biology, tissue engineering, medicine, drug discovery and cosmetic, aiming to produce functional biological construct that mimic the complexity of natural tissues and organs. The demand for organ transplantation has rapidly grown over the past two decades. Worldwide increases in the incidence of end stage organ failure combined with rising successes in post transplantation outcomes has resulted in an organ shortage crisis, as the demand for organ vastly outstrips supply.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR6.3%


Bioprinting Technologies is a fragmented market due to the presence of various players. The players are focusing on strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Bioprinting Technologies market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Envisiontec Inc. (United States), Organovo Holding Inc. (United States), Cyfuse Biomedical K.K (Japan), 3D Bioprinting Solutions (Russia), Inventia Life Science PTY LTD. (United States), Poietis (France), Vivax Bio LLC (United States), Bico Group (Sweden), Cellink Global (Sweden), 3D Bio Corp. (United States), 3D Systems (United States), BioBots Inc. (United States) and TeVido Biodevices (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are 3D Dynamic Systems (United States), GeSIM GmBH (Germany) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Bioprinting Technologies market by , Application (Tissue Engineering, Drug Development/ Screening, Toxicology Screening, Tissue Model for Cancer Research and Others) and Region.



On the basis of geography, the market of Bioprinting Technologies has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Microextrusion Bioprinting will boost the Bioprinting Technologies market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Material, the sub-segment i.e. Living Cells will boost the Bioprinting Technologies market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Pharmaceutical & Biotechnology will boost the Bioprinting Technologies market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
FDA approved 3D printed drug paved new path for increased precision in patient care. and Market developing product in line with regulatory laws.

Market Growth Drivers:
Increasing use of 3D bioprinting in the pharmaceutical and cosmetic industries., Growing high demand for transplantable tissues and organ., Surging geriatric population with chronic respiratory diseases. and Lack of organ donor

Challenges:
Process management and knowledge of 3D printers.

Restraints:
Lack of skilled professionals. and High cost.

Opportunities:
Technological innovation including improved printing precision and bioink formulation. and Expansion of cancer research.

Market Leaders and their expansionary development strategies
In May 2022, Bico acquired Allegro 3D, adding new light based 3D bioprinting technology. Bico Boprinting to strengthen its position as the global leader in providing 3D bioprinters. Bico robust portfolio of bioprinters, utilizing extrusion based, 2PP and DLP technologies.
In March 2022, Brinter launched new medical print head with puredyne to enable precise and repeatable bioprinting. The head mean more material diversity for dispensing, repeatability with a continuous and precise printing process, and zero cross contamination due to the use of a single cartridge per material. Due to the dispensing geometry, a constant volume per revolution always conveyed and precisely applied, meaning almost zero dead volume can be achieved.


Key Target Audience
3D bioprinting service provider, Healthcare Industries, Academic Institute, Raw Material Manufacturer, Research Organization, Investor, Regulatory Authorities and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Tissue Engineering
  • Drug Development/ Screening
  • Toxicology Screening
  • Tissue Model for Cancer Research
  • Others
By Technology
  • Microextrusion Bioprinting
  • Inkjet 3D Bioprinting
  • Laser assisted Bioprinting
  • Stereo lithography
  • Others

By Material
  • Living Cells
  • Hydrogels
  • Extracellular Matrices

By End User
  • Pharmaceutical & Biotechnology
  • Research & Organization
  • Academic Institute
  • Hospital
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing use of 3D bioprinting in the pharmaceutical and cosmetic industries.
      • 3.2.2. Growing high demand for transplantable tissues and organ.
      • 3.2.3. Surging geriatric population with chronic respiratory diseases.
      • 3.2.4. Lack of organ donor
    • 3.3. Market Challenges
      • 3.3.1. Process management and knowledge of 3D printers.
    • 3.4. Market Trends
      • 3.4.1. FDA approved 3D printed drug paved new path for increased precision in patient care.
      • 3.4.2. Market developing product in line with regulatory laws.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Bioprinting Technologies, by Application, Technology, Material, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Bioprinting Technologies (Value)
      • 5.2.1. Global Bioprinting Technologies by: Application (Value)
        • 5.2.1.1. Tissue Engineering
        • 5.2.1.2. Drug Development/ Screening
        • 5.2.1.3. Toxicology Screening
        • 5.2.1.4. Tissue Model for Cancer Research
        • 5.2.1.5. Others
      • 5.2.2. Global Bioprinting Technologies by: Technology (Value)
        • 5.2.2.1. Microextrusion Bioprinting
        • 5.2.2.2. Inkjet 3D Bioprinting
        • 5.2.2.3. Laser assisted Bioprinting
        • 5.2.2.4. Stereo lithography
        • 5.2.2.5. Others
      • 5.2.3. Global Bioprinting Technologies by: Material (Value)
        • 5.2.3.1. Living Cells
        • 5.2.3.2. Hydrogels
        • 5.2.3.3. Extracellular Matrices
      • 5.2.4. Global Bioprinting Technologies by: End User (Value)
        • 5.2.4.1. Pharmaceutical & Biotechnology
        • 5.2.4.2. Research & Organization
        • 5.2.4.3. Academic Institute
        • 5.2.4.4. Hospital
        • 5.2.4.5. Others
      • 5.2.5. Global Bioprinting Technologies Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Bioprinting Technologies: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Envisiontec Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Organovo Holding Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cyfuse Biomedical K.K (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. 3D Bioprinting Solutions (Russia)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Inventia Life Science PTY LTD. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Poietis (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Vivax Bio LLC (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bico Group (Sweden)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Cellink Global (Sweden)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. 3D Bio Corp. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. 3D Systems (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. BioBots Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. TeVido Biodevices (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Bioprinting Technologies Sale, by Application, Technology, Material, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Bioprinting Technologies (Value)
      • 7.2.1. Global Bioprinting Technologies by: Application (Value)
        • 7.2.1.1. Tissue Engineering
        • 7.2.1.2. Drug Development/ Screening
        • 7.2.1.3. Toxicology Screening
        • 7.2.1.4. Tissue Model for Cancer Research
        • 7.2.1.5. Others
      • 7.2.2. Global Bioprinting Technologies by: Technology (Value)
        • 7.2.2.1. Microextrusion Bioprinting
        • 7.2.2.2. Inkjet 3D Bioprinting
        • 7.2.2.3. Laser assisted Bioprinting
        • 7.2.2.4. Stereo lithography
        • 7.2.2.5. Others
      • 7.2.3. Global Bioprinting Technologies by: Material (Value)
        • 7.2.3.1. Living Cells
        • 7.2.3.2. Hydrogels
        • 7.2.3.3. Extracellular Matrices
      • 7.2.4. Global Bioprinting Technologies by: End User (Value)
        • 7.2.4.1. Pharmaceutical & Biotechnology
        • 7.2.4.2. Research & Organization
        • 7.2.4.3. Academic Institute
        • 7.2.4.4. Hospital
        • 7.2.4.5. Others
      • 7.2.5. Global Bioprinting Technologies Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bioprinting Technologies: by Application(USD Million)
  • Table 2. Bioprinting Technologies Tissue Engineering , by Region USD Million (2018-2023)
  • Table 3. Bioprinting Technologies Drug Development/ Screening , by Region USD Million (2018-2023)
  • Table 4. Bioprinting Technologies Toxicology Screening , by Region USD Million (2018-2023)
  • Table 5. Bioprinting Technologies Tissue Model for Cancer Research , by Region USD Million (2018-2023)
  • Table 6. Bioprinting Technologies Others , by Region USD Million (2018-2023)
  • Table 7. Bioprinting Technologies: by Technology(USD Million)
  • Table 8. Bioprinting Technologies Microextrusion Bioprinting , by Region USD Million (2018-2023)
  • Table 9. Bioprinting Technologies Inkjet 3D Bioprinting , by Region USD Million (2018-2023)
  • Table 10. Bioprinting Technologies Laser assisted Bioprinting , by Region USD Million (2018-2023)
  • Table 11. Bioprinting Technologies Stereo lithography , by Region USD Million (2018-2023)
  • Table 12. Bioprinting Technologies Others , by Region USD Million (2018-2023)
  • Table 13. Bioprinting Technologies: by Material(USD Million)
  • Table 14. Bioprinting Technologies Living Cells , by Region USD Million (2018-2023)
  • Table 15. Bioprinting Technologies Hydrogels , by Region USD Million (2018-2023)
  • Table 16. Bioprinting Technologies Extracellular Matrices , by Region USD Million (2018-2023)
  • Table 17. Bioprinting Technologies: by End User(USD Million)
  • Table 18. Bioprinting Technologies Pharmaceutical & Biotechnology , by Region USD Million (2018-2023)
  • Table 19. Bioprinting Technologies Research & Organization , by Region USD Million (2018-2023)
  • Table 20. Bioprinting Technologies Academic Institute , by Region USD Million (2018-2023)
  • Table 21. Bioprinting Technologies Hospital , by Region USD Million (2018-2023)
  • Table 22. Bioprinting Technologies Others , by Region USD Million (2018-2023)
  • Table 23. South America Bioprinting Technologies, by Country USD Million (2018-2023)
  • Table 24. South America Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 25. South America Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 26. South America Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 27. South America Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 28. Brazil Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 29. Brazil Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 30. Brazil Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 31. Brazil Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 32. Argentina Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 33. Argentina Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 34. Argentina Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 35. Argentina Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 36. Rest of South America Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 37. Rest of South America Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 38. Rest of South America Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 39. Rest of South America Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 40. Asia Pacific Bioprinting Technologies, by Country USD Million (2018-2023)
  • Table 41. Asia Pacific Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 42. Asia Pacific Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 43. Asia Pacific Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 44. Asia Pacific Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 45. China Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 46. China Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 47. China Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 48. China Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 49. Japan Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 50. Japan Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 51. Japan Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 52. Japan Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 53. India Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 54. India Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 55. India Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 56. India Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 57. South Korea Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 58. South Korea Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 59. South Korea Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 60. South Korea Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 61. Taiwan Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 62. Taiwan Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 63. Taiwan Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 64. Taiwan Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 65. Australia Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 66. Australia Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 67. Australia Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 68. Australia Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 72. Rest of Asia-Pacific Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 73. Europe Bioprinting Technologies, by Country USD Million (2018-2023)
  • Table 74. Europe Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 75. Europe Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 76. Europe Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 77. Europe Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 78. Germany Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 79. Germany Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 80. Germany Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 81. Germany Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 82. France Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 83. France Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 84. France Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 85. France Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 86. Italy Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 87. Italy Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 88. Italy Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 89. Italy Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 90. United Kingdom Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 91. United Kingdom Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 92. United Kingdom Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 93. United Kingdom Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 94. Netherlands Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 95. Netherlands Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 96. Netherlands Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 97. Netherlands Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 98. Rest of Europe Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 99. Rest of Europe Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 100. Rest of Europe Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 101. Rest of Europe Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 102. MEA Bioprinting Technologies, by Country USD Million (2018-2023)
  • Table 103. MEA Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 104. MEA Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 105. MEA Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 106. MEA Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 107. Middle East Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 108. Middle East Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 109. Middle East Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 110. Middle East Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 111. Africa Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 112. Africa Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 113. Africa Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 114. Africa Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 115. North America Bioprinting Technologies, by Country USD Million (2018-2023)
  • Table 116. North America Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 117. North America Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 118. North America Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 119. North America Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 120. United States Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 121. United States Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 122. United States Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 123. United States Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 124. Canada Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 125. Canada Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 126. Canada Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 127. Canada Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 128. Mexico Bioprinting Technologies, by Application USD Million (2018-2023)
  • Table 129. Mexico Bioprinting Technologies, by Technology USD Million (2018-2023)
  • Table 130. Mexico Bioprinting Technologies, by Material USD Million (2018-2023)
  • Table 131. Mexico Bioprinting Technologies, by End User USD Million (2018-2023)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Bioprinting Technologies: by Application(USD Million)
  • Table 146. Bioprinting Technologies Tissue Engineering , by Region USD Million (2025-2030)
  • Table 147. Bioprinting Technologies Drug Development/ Screening , by Region USD Million (2025-2030)
  • Table 148. Bioprinting Technologies Toxicology Screening , by Region USD Million (2025-2030)
  • Table 149. Bioprinting Technologies Tissue Model for Cancer Research , by Region USD Million (2025-2030)
  • Table 150. Bioprinting Technologies Others , by Region USD Million (2025-2030)
  • Table 151. Bioprinting Technologies: by Technology(USD Million)
  • Table 152. Bioprinting Technologies Microextrusion Bioprinting , by Region USD Million (2025-2030)
  • Table 153. Bioprinting Technologies Inkjet 3D Bioprinting , by Region USD Million (2025-2030)
  • Table 154. Bioprinting Technologies Laser assisted Bioprinting , by Region USD Million (2025-2030)
  • Table 155. Bioprinting Technologies Stereo lithography , by Region USD Million (2025-2030)
  • Table 156. Bioprinting Technologies Others , by Region USD Million (2025-2030)
  • Table 157. Bioprinting Technologies: by Material(USD Million)
  • Table 158. Bioprinting Technologies Living Cells , by Region USD Million (2025-2030)
  • Table 159. Bioprinting Technologies Hydrogels , by Region USD Million (2025-2030)
  • Table 160. Bioprinting Technologies Extracellular Matrices , by Region USD Million (2025-2030)
  • Table 161. Bioprinting Technologies: by End User(USD Million)
  • Table 162. Bioprinting Technologies Pharmaceutical & Biotechnology , by Region USD Million (2025-2030)
  • Table 163. Bioprinting Technologies Research & Organization , by Region USD Million (2025-2030)
  • Table 164. Bioprinting Technologies Academic Institute , by Region USD Million (2025-2030)
  • Table 165. Bioprinting Technologies Hospital , by Region USD Million (2025-2030)
  • Table 166. Bioprinting Technologies Others , by Region USD Million (2025-2030)
  • Table 167. South America Bioprinting Technologies, by Country USD Million (2025-2030)
  • Table 168. South America Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 169. South America Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 170. South America Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 171. South America Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 172. Brazil Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 173. Brazil Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 174. Brazil Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 175. Brazil Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 176. Argentina Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 177. Argentina Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 178. Argentina Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 179. Argentina Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 180. Rest of South America Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 181. Rest of South America Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 182. Rest of South America Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 183. Rest of South America Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 184. Asia Pacific Bioprinting Technologies, by Country USD Million (2025-2030)
  • Table 185. Asia Pacific Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 186. Asia Pacific Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 187. Asia Pacific Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 188. Asia Pacific Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 189. China Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 190. China Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 191. China Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 192. China Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 193. Japan Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 194. Japan Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 195. Japan Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 196. Japan Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 197. India Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 198. India Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 199. India Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 200. India Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 201. South Korea Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 202. South Korea Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 203. South Korea Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 204. South Korea Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 205. Taiwan Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 206. Taiwan Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 207. Taiwan Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 208. Taiwan Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 209. Australia Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 210. Australia Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 211. Australia Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 212. Australia Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 213. Rest of Asia-Pacific Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 214. Rest of Asia-Pacific Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 215. Rest of Asia-Pacific Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 216. Rest of Asia-Pacific Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 217. Europe Bioprinting Technologies, by Country USD Million (2025-2030)
  • Table 218. Europe Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 219. Europe Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 220. Europe Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 221. Europe Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 222. Germany Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 223. Germany Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 224. Germany Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 225. Germany Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 226. France Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 227. France Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 228. France Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 229. France Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 230. Italy Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 231. Italy Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 232. Italy Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 233. Italy Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 234. United Kingdom Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 235. United Kingdom Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 236. United Kingdom Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 237. United Kingdom Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 238. Netherlands Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 239. Netherlands Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 240. Netherlands Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 241. Netherlands Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 242. Rest of Europe Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 243. Rest of Europe Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 244. Rest of Europe Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 245. Rest of Europe Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 246. MEA Bioprinting Technologies, by Country USD Million (2025-2030)
  • Table 247. MEA Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 248. MEA Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 249. MEA Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 250. MEA Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 251. Middle East Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 252. Middle East Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 253. Middle East Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 254. Middle East Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 255. Africa Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 256. Africa Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 257. Africa Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 258. Africa Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 259. North America Bioprinting Technologies, by Country USD Million (2025-2030)
  • Table 260. North America Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 261. North America Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 262. North America Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 263. North America Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 264. United States Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 265. United States Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 266. United States Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 267. United States Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 268. Canada Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 269. Canada Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 270. Canada Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 271. Canada Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 272. Mexico Bioprinting Technologies, by Application USD Million (2025-2030)
  • Table 273. Mexico Bioprinting Technologies, by Technology USD Million (2025-2030)
  • Table 274. Mexico Bioprinting Technologies, by Material USD Million (2025-2030)
  • Table 275. Mexico Bioprinting Technologies, by End User USD Million (2025-2030)
  • Table 276. Research Programs/Design for This Report
  • Table 277. Key Data Information from Secondary Sources
  • Table 278. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bioprinting Technologies: by Application USD Million (2018-2023)
  • Figure 5. Global Bioprinting Technologies: by Technology USD Million (2018-2023)
  • Figure 6. Global Bioprinting Technologies: by Material USD Million (2018-2023)
  • Figure 7. Global Bioprinting Technologies: by End User USD Million (2018-2023)
  • Figure 8. South America Bioprinting Technologies Share (%), by Country
  • Figure 9. Asia Pacific Bioprinting Technologies Share (%), by Country
  • Figure 10. Europe Bioprinting Technologies Share (%), by Country
  • Figure 11. MEA Bioprinting Technologies Share (%), by Country
  • Figure 12. North America Bioprinting Technologies Share (%), by Country
  • Figure 13. Global Bioprinting Technologies share by Players 2023 (%)
  • Figure 14. Global Bioprinting Technologies share by Players (Top 3) 2023(%)
  • Figure 15. Global Bioprinting Technologies share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Envisiontec Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Envisiontec Inc. (United States) Revenue: by Geography 2023
  • Figure 19. Organovo Holding Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Organovo Holding Inc. (United States) Revenue: by Geography 2023
  • Figure 21. Cyfuse Biomedical K.K (Japan) Revenue, Net Income and Gross profit
  • Figure 22. Cyfuse Biomedical K.K (Japan) Revenue: by Geography 2023
  • Figure 23. 3D Bioprinting Solutions (Russia) Revenue, Net Income and Gross profit
  • Figure 24. 3D Bioprinting Solutions (Russia) Revenue: by Geography 2023
  • Figure 25. Inventia Life Science PTY LTD. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Inventia Life Science PTY LTD. (United States) Revenue: by Geography 2023
  • Figure 27. Poietis (France) Revenue, Net Income and Gross profit
  • Figure 28. Poietis (France) Revenue: by Geography 2023
  • Figure 29. Vivax Bio LLC (United States) Revenue, Net Income and Gross profit
  • Figure 30. Vivax Bio LLC (United States) Revenue: by Geography 2023
  • Figure 31. Bico Group (Sweden) Revenue, Net Income and Gross profit
  • Figure 32. Bico Group (Sweden) Revenue: by Geography 2023
  • Figure 33. Cellink Global (Sweden) Revenue, Net Income and Gross profit
  • Figure 34. Cellink Global (Sweden) Revenue: by Geography 2023
  • Figure 35. 3D Bio Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 36. 3D Bio Corp. (United States) Revenue: by Geography 2023
  • Figure 37. 3D Systems (United States) Revenue, Net Income and Gross profit
  • Figure 38. 3D Systems (United States) Revenue: by Geography 2023
  • Figure 39. BioBots Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. BioBots Inc. (United States) Revenue: by Geography 2023
  • Figure 41. TeVido Biodevices (United States) Revenue, Net Income and Gross profit
  • Figure 42. TeVido Biodevices (United States) Revenue: by Geography 2023
  • Figure 43. Global Bioprinting Technologies: by Application USD Million (2025-2030)
  • Figure 44. Global Bioprinting Technologies: by Technology USD Million (2025-2030)
  • Figure 45. Global Bioprinting Technologies: by Material USD Million (2025-2030)
  • Figure 46. Global Bioprinting Technologies: by End User USD Million (2025-2030)
  • Figure 47. South America Bioprinting Technologies Share (%), by Country
  • Figure 48. Asia Pacific Bioprinting Technologies Share (%), by Country
  • Figure 49. Europe Bioprinting Technologies Share (%), by Country
  • Figure 50. MEA Bioprinting Technologies Share (%), by Country
  • Figure 51. North America Bioprinting Technologies Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Envisiontec Inc. (United States)
  • Organovo Holding Inc. (United States)
  • Cyfuse Biomedical K.K (Japan)
  • 3D Bioprinting Solutions (Russia)
  • Inventia Life Science PTY LTD. (United States)
  • Poietis (France)
  • Vivax Bio LLC (United States)
  • Bico Group (Sweden)
  • Cellink Global (Sweden)
  • 3D Bio Corp. (United States)
  • 3D Systems (United States)
  • BioBots Inc. (United States)
  • TeVido Biodevices (United States)
Additional players considered in the study are as follows:
3D Dynamic Systems (United States) , GeSIM GmBH (Germany) , Others
Select User Access Type

Key Highlights of Report


Jan 2024 219 Pages 79 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Bioprinting Technologies Market Quantitative research analysis
Global Bioprinting Technologies Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Envisiontec Inc. (United States), Organovo Holding Inc. (United States), Cyfuse Biomedical K.K (Japan), 3D Bioprinting Solutions (Russia), Inventia Life Science PTY LTD. (United States), Poietis (France), Vivax Bio LLC (United States), Bico Group (Sweden), Cellink Global (Sweden), 3D Bio Corp. (United States), 3D Systems (United States), BioBots Inc. (United States) and TeVido Biodevices (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"FDA approved 3D printed drug paved new path for increased precision in patient care. " is seen as one of major influencing trends for Bioprinting Technologies Market during projected period 2023-2030.
The Bioprinting Technologies market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Bioprinting Technologies Market Report?

Have a Query? Click Here

Other Related Reports

Digital Mental Health Comprehensive Study by Type (Telehealth & Teletherapy, Tracking & Self-Help Apps, Meditation Apps, Digital Therapeutics), End Users (Hospitals, Specialty Clinics, Research Insti...
$ 3800
AI-Assisted Radiology Comprehensive Study by Application (Breast Imaging, Respiratory & Pulmonary, Neurology, Orthopedics, Others), Techniques (Ultrasound (US), CT-Scan, Positron Emission Tomography ...
$ 3800